Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations

被引:10
|
作者
Peters, Tanja [1 ]
Soanes, Nigel [2 ]
Abbas, Maya [3 ]
Ahmad, Jabeen [4 ]
Delumeau, Jean-Christophe [5 ]
Herrero-Martinez, Esteban [6 ]
Paramananda, Melanie [7 ]
Piper, Johanna [8 ]
Smail-Aoudia, Fairouz [7 ]
van der Spuij, Willemijn [9 ]
Veizovic, Tina [10 ]
Winstanley, Gillian [11 ]
机构
[1] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[2] AstraZeneca PLC, Cambridge, England
[3] Johnson & Johnson Middle East, Beirut, Lebanon
[4] Innovate PV, London, England
[5] Bayer Pharma, Singapore, Singapore
[6] AbbVie Ltd, Maidenhead, Berks, England
[7] Pierre Fabre Medicament, Boulogne, France
[8] Roche Prod Ltd, Welwyn Garden City, Herts, England
[9] Bristol Myers Squibb, Steinhausen, Switzerland
[10] Takeda, London, England
[11] Amgen Canada Inc, Mississauga, ON, Canada
关键词
D O I
10.1007/s40264-020-01008-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Pharmaceutical legislation provides a legal framework to ensure the safe and effective use of medicines. This framework requires national regulatory authorities (NRAs) to establish and maintain a pharmacovigilance system (PV system) stating and enforcing the regulatory commitments that key stakeholders, including marketing authorisation holders (MAHs), are required to fulfil. In recent years, national legislative bodies and NRAs across the world have issued a significant amount of legislation and guidance enforcing the obligation to perform pharmacovigilance activities. In countries where the NRA is a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), safety management requirements are generally consistent with ICH guidelines. In a number of countries beyond this scope, requirements may deviate from internationally agreed standards, adding a substantial complexity and increasing burden on the stakeholders involved, whilst the benefit for patients' safety may not be evident. Committed to fulfilling safety-regulatory obligations in any country where a product licence is held, global pharmaceutical companies have accumulated a broad and deep experience acquired whilst meeting the expectations of a large array of diverse PV systems across the world. These range from sub-optimal frameworks, according to the World Health Organization (WHO) Global Benchmarking Tool, to highly effective resource-optimised PV systems. In order to support countries creating or further developing their PV systems, especially where infrastructure and resources are limited, the European Federation of Pharmaceutical Industries and Associations (EFPIA) International Pharmacovigilance Group (IPVG) has developed consensus recommendations consistent with harmonised standards for the development and step-wise implementation of key PV system components. These recommendations endorsed by the EFPIA membership constitute the focus of this review article.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [41] Intestinal Mucosal Defense System, Part 1. Consensus Recommendations for Immunonutrients
    Neu, Josef
    Mihatsch, Walter A.
    Zegarra, Jaime
    Supapannachart, Sarayut
    Ding, Zong-Yi
    Murguia-Peniche, Teresa
    JOURNAL OF PEDIATRICS, 2013, 162 (03): : S56 - S63
  • [42] DEVELOPMENT OF CONSENSUS RECOMMENDATIONS FOR THE IDENTIFICATION AND TREATMENT OF TSC-ASSOCIATED NEUROPSYCHIATRIC DISORDERS (TAND)
    Chambers, N.
    Heunis, T. -M.
    Vanclooster, S.
    de Waele, L.
    Jansen, A. C.
    de Vries, P. J.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2023, 67 (09) : 807 - 807
  • [43] Recommendations from a consensus development workshop on the diagnosis of fetal alcohol spectrum disorders in Australia
    Rochelle E Watkins
    Elizabeth J Elliott
    Amanda Wilkins
    Raewyn C Mutch
    James P Fitzpatrick
    Janet M Payne
    Colleen M O’Leary
    Heather M Jones
    Jane Latimer
    Lorian Hayes
    Jane Halliday
    Heather D’Antoine
    Sue Miers
    Elizabeth Russell
    Lucinda Burns
    Anne McKenzie
    Elizabeth Peadon
    Maureen Carter
    Carol Bower
    BMC Pediatrics, 13
  • [44] Recommendations from a consensus development workshop on the diagnosis of fetal alcohol spectrum disorders in Australia
    Watkins, Rochelle E.
    Elliott, Elizabeth J.
    Wilkins, Amanda
    Mutch, Raewyn C.
    Fitzpatrick, James P.
    Payne, Janet M.
    O'Leary, Colleen M.
    Jones, Heather M.
    Latimer, Jane
    Hayes, Lorian
    Halliday, Jane
    D'Antoine, Heather
    Miers, Sue
    Russell, Elizabeth
    Burns, Lucinda
    McKenzie, Anne
    Peadon, Elizabeth
    Carter, Maureen
    Bower, Carol
    BMC PEDIATRICS, 2013, 13
  • [45] Design and Analysis of an Effective Securing Consensus Scheme for Decentralized Blockchain System
    Wang, Jing
    Wang, Lingfu
    Yeh, Wei-Chang
    Wang, Jinhai
    BLOCKCHAIN AND TRUSTWORTHY SYSTEMS, BLOCKSYS 2019, 2020, 1156 : 212 - 225
  • [46] Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists
    Dars, Sindhrani
    Buckley, Elizabeth
    Beckmann, Kerri
    Roder, David
    Banwell, Helen
    JOURNAL OF FOOT AND ANKLE RESEARCH, 2023, 16 (01)
  • [47] Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists
    Sindhrani Dars
    Elizabeth Buckley
    Kerri Beckmann
    David Roder
    Helen Banwell
    Journal of Foot and Ankle Research, 16
  • [48] Effective clutch-system development
    Effiziente Entwicklung von kupplungssystemen
    2001, Friedr. Vieweg und Sohn Verlags GmbH (103)
  • [49] The development of an effective safety management system
    Davies, RW
    IRPA9 - 1996 INTERNATIONAL CONGRESS ON RADIATION PROTECTION / NINTH INTERNATIONAL CONGRESS OF THE INTERNATIONAL RADIATION PROTECTION ASSOCIATION, PROCEEDINGS, VOL 4, 1996, : D547 - D549
  • [50] Creation of consensus recommendations for collaborative practice in the Malaysian psychiatric system: a modified Delphi study
    Wendy Shoesmith
    Sze Hung Chua
    Beena Giridharan
    Dawn Forman
    Sue Fyfe
    International Journal of Mental Health Systems, 14